alexa Barlows syndrome | Mexico| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Barlows Syndrome

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Barlows syndrome

    Barlow syndrome is mitral valve prolapse (also known as "click murmur syndrome"), the most common heart valve abnormality, affecting 5-10% of the world population. Most patients have no symptoms and require no treatment. However, the condition can be associated with fatigue and/or palpitations. The mitral valve prolapse can often be detected by a doctor during examination of the heart and can be confirmed with anechocardiogram. Patients are usually given antibiotics prior to any procedure which might introduce bacteria into the bloodstream, including dental work and minor surgery.

  • Barlows syndrome

    Causes: The underlying problem with the valve is a degeneration of the tissue causing the leaflets to become stretched and enlarged. This redundant tissue bulges into the atrium, preventing the valve from closing properly. The exact reason for this tissue change is not known, but it is associated with the tissue degenerative disorders. Functional MVP can occur with completely normal valve leaflets: this is found in conditions of abnormal papillary muscle function due to myocardial ischaemia, and in dilated cardiomyopathy. Patients with hypertrophic cardiomyopathy are also at risk.

  • Barlows syndrome

    Symptoms: Most patients do not experience symptoms. However, when they do the symptoms include: • Fatigue  Migraine  Dizziness  Panic attacks  Low blood pressure when lying down  Shortness of breath  Palpitations  Chest pain that is not angina However, these non-specific symptoms are not reliable indicators of the condition. When the doctor listens to the heart, a murmur may be heard. This is caused by irregular blood flow through the valve. A click may also be heard, thought to be due to the snapping of the anchoring “ropes” – the chordea – as the valve billows and then is suddenly held taut. This is much like the snapping taut of the sails on a boat. These sounds are often transient or absent, and might only be detected by an experienced cardiologist. If there are problems with the function of the left ventricle, the patient may experience shortness of breath and troublesome irregularities of heart rhythm. Barlow’s syndrome may result in severe dysfunction of the mitral valve, leading to what is called mitral regurgitation (MR), a leaking, or incompetent valve. Mitral regurgitation means that blood flows back into the left atrium during contraction rather than moving forwards into the aorta as it should do. About 25% of people with Barlow's syndrome also suffer from lax joints, and a high arched palate in the mouth (these patients may also have a degree of Marfan's syndrome), and other abnormalities of their skeleton such as scoliosis, a funnel chest and a straight back.

  • Barlows syndrome

    Treatment: Individuals with mitral valve prolapse, particularly those without symptoms, often require no treatment. Those with mitral valve prolapse and symptoms of dysautonomia (palpitations, chest pain) may benefit from beta-blockers (e.g., propranolol). Patients with prior stroke and/or atrial fibrillation may require blood thinners, such as aspirin or warfarin. In rare instances when mitral valve prolapse is associated with severe mitral regurgitation, mitral valve repair or surgical replacement may be necessary. Mitral valve repair is generally considered preferable to replacement. Current ACC/AHA guidelines promote repair of mitral valve in patients before symptoms of heart failure develop. Symptomatic patients, those with evidence of diminished left ventricular function, or those with left ventricular dilatation need urgent attention.

  • Barlows syndrome

    Statistics: The prevalence of metabolic syndrome fell significantly from 44% to 16% (P < 0.01), high blood pressure fell from 19% to 0%, hypertrigliceridaemia fell from 64% to 35%, high-density lipoprotein-cholesterol ≤ 40 fell from 60% to 41%, hyperglycaemia fell from 1% to 0%, and waist circumference ≥90th percentile fell from 72% to 57%. There was a 2.84 [95% confidence interval (CI) = −4.10 to −1.58;P < 0.01] significant decrease in body mass index percentile and in body-fat percentage (95% CI = −3.31 to −1.55; P < 0.01). Of the overweight children, 32% achieved normal-weight, whereas 24% of the obese ones converted to overweight and 1% reached normal-weight. Physical activity increased 16 min day–1 (P = 0.02) and 2 days week–1. After adjusting for age and sex interactions, body mass index, homeostasis model of assessment—insulin resistance, total cholesterol, triglycerides, high density lipoproteins and use of lipid lowering drugs, dihydroceramides as a class were associated with WC. Dihydroceramide species 18:0, 20:0, 22:0, and 24:1 were significantly associated and genetically correlated with WC. Two sphingomyelin species (31:1 and 41:1) were also associated with WC. Cross-sectional data on lipidomic profiles and WC was available on 1208 subjects representing 42 extended families. The mean age of the study sample was 37.0 (SD 14.39) years and there were 292 (36.1%) males. Prevalence of IR was 74.6% based on a HOMA-IR cut-off of 2.6 (the commonly used clinical cut-point for IR) and 56.1% using a cut-off of 3.8 (as specifically recommended [34] for Mexican-American populations). The prevalence of T2D and obesity in this sample was 14.8 and 38.3%, respectively.

Expert PPTs

Speaker PPTs


High Impact List of Articles

Conference Proceedings